logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Windlas Biotech Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    543329
    INE0H5O01029
    225.6263821
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    WINDLAS
    32.73
    2002.15
    EPS(TTM)
    Face Value()
    Div & Yield %:
    29.27
    5
    0.57
     
Contil India Ltd
Contil India standalone net profit rises 191.67% in the June 2024 quarter
Aug 10,2024
Net profit of Contil India rose 191.67% to Rs 0.35 crore in the quarter ended June 2024 as against Rs 0.12 crore during the previous quarter ended June 2023. Sales rose 52.45% to Rs 8.72 crore in the quarter ended June 2024 as against Rs 5.72 crore during the previous quarter ended June 2023.

ParticularsQuarter Ended
Jun. 2024Jun. 2023% Var.
Sales8.725.72 52
OPM %2.98-1.05 -
PBDT0.480.17 182
PBT0.470.16 194
NP0.350.12 192